Navigation Links
Cancer patients under-referred for orthopedic oncology services
Date:4/2/2012

There is a disconnect between the number of cancer patients estimated to have bone metastases and the number of patients who are sent for orthopedic care each year, states an article in the Canadian Journal of Surgery (CJS).

Almost half of the 140 000 new cases of cancer diagnosed in Canada each year can spread to the bones, but very few of these patients are referred to orthopedic services even though they could benefit in terms of quality of life, less pain and better outcomes if their bones could be prevented from breaking.

Researchers in the Division of Orthopaedic Trauma at the Vancouver General Hospital (VGH) reviewed the cases of all cancer patients treated for bone lesions or fractures caused by bone lesions at their hospital over a 20-year period and found that an average of only 13 out of a possible 14 000 patients per year received orthopedic care.

"It seems there is reluctance to consider surgery or ignorance of what additional benefit orthopedics can offer," the authors state. Surgical procedures aren't without risk, which may explain the reluctance.

Among the patients included in the study, survival ranged from less than one year to more than 18 years, and 14% died in hospital care. "The mortality rate does seem high, but many procedures were undertaken as palliative interventions as part of the patients' final care," the authors explain. They go on to state that their results suggest that failure to seek a timely surgical opinion may contribute to some of the poor outcomes reported.

"Engaging with oncologists to consider available orthopedic interventions might provide more effective overall care in patients with [cancer that has spread to the bones]," the authors state.


'/>"/>

Contact: Dr. Michael Kelly
Michael.Kelly2@nbt.nhs.uk
44-117-340-3683
Canadian Journal of Surgery
Source:Eurekalert

Page: 1

Related medicine news :

1. Enhancing arrest of cell growth to treat cancer in mice
2. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
3. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
4. Low forms of cyclin E reduce breast cancer drugs effectiveness
5. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
6. Soft drinks may increase risk of pancreatic cancer
7. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
8. Genes Play Role in Prognosis With Non-Small Cell Lung Cancers
9. Single gene mutation induces endometrial cancer
10. Certain genetic profiles associated with recurrence-free survival for non-small cell lung cancer
11. Molecular pathways linked to sex, age affect outcomes in lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... VA (PRWEB) , ... June 23, 2017 , ... ... of what is needed and will ultimately do significant harm to people with ... to everyone. , "While it leaves in place the Affordable Care Act ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids and ... of visual loss in these patients. , But how often do ophthalmologists and optometrists ... to patients at risk of or with early symptoms of AMD? A study ...
(Date:6/23/2017)... ... 2017 , ... Military Connection friend and veteran advocate Micaela Bensko ... Atlantic lounge. , Bensko is no stranger to the plight of the disabled. ... life to supporting our wounded veterans. A world-class photographer, her riveting photos “The Wounds ...
(Date:6/23/2017)... ... 2017 , ... The Aesthetic Channel has recently highlighted Dr. Ben Talei’s unique ... a proprietary technique that he calls the AuraLyft Facelift. The AuraLyft does ... patients can expect to look refreshed, rejuvenated, and revitalized. , Dr. Talei’s unique ...
(Date:6/23/2017)... ... June 23, 2017 , ... 21 Middle East and South Asia ... 21 leaders from government, business and civil society in 11 countries across the Middle ... fall, engaging in a transformative exchange of knowledge and ideas with the leading minds ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 2017  StatLab Medical Products ("StatLab" or ... of diagnostic supplies for the anatomic pathology ... Company LP ("Cressey & Company"), a healthcare-focused ... investment in the Company. Cressey & Company ... selling shareholder, Prairie Capital, L.P., with certain ...
(Date:6/7/2017)... 2017  Diplomat Specialty Infusion Group, a brand of Diplomat Pharmacy, ... Iowa location. The ... features an ISO 7 cleanroom—the standard needed to compound intravenous (IV) ... level of pollutants. "Our new ... better serve our Iowa patients," said ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: